Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

Huadian Liaoning Energy Development (600396.SH) plans to increase capital by 100 million yuan to Huadian (Liaoning) Energy Sales Co., Ltd.

CLOUDBREAK-B(02592) has successfully applied for patents in Japan and Europe, which will enhance and accelerate the global commercialization potential of CBT-009.

VEEKO INT'L (01173) released its interim performance, with a loss of HKD 40.45 million in this period, a year-on-year decrease of 16.93%.
Huadian Liaoning Energy Development (600396.SH) plans to increase capital by 100 million yuan to Huadian (Liaoning) Energy Sales Co., Ltd.

CLOUDBREAK-B(02592) has successfully applied for patents in Japan and Europe, which will enhance and accelerate the global commercialization potential of CBT-009.

VEEKO INT'L (01173) released its interim performance, with a loss of HKD 40.45 million in this period, a year-on-year decrease of 16.93%.

RECOMMEND

Food Delivery Ceasefire: Chinese Concept Stocks Reach Dual Inflection In Value And Technology — From Cash‑Burning Rivalry To An AI‑Led Strategic Upgrade
27/11/2025

Six Departments Issue Joint Plan To Boost Consumption And Improve Supply‑Demand Alignment For Consumer Goods
27/11/2025

Citi Research On China’s Humanoid Robot Industry: Broad Optimism, Exponential Growth Likely In 2026, At Least A Doubling
27/11/2025


